1. Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors
   Tae Nakano-Tateno et al, 2021, Frontiers in Endocrinology CrossRef
2. Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis
   P. Trillo Aliaga et al, 2021, Cancer Treatment Reviews CrossRef
3. Chemotherapy in Neuroendocrine Tumors
   Satya Das et al, 2021, Cancers CrossRef
4. Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
   Katharine Thomas et al, 2020, Cancers CrossRef
5. Glioblastoma under Siege: An Overview of Current Therapeutic Strategies
   Mayra Paolillo et al, 2018, Brain Sciences CrossRef
6. Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms
   Eleftherios Chatzellis et al, 2019, Neuroendocrinology CrossRef
7. Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
   Louis de Mestier et al, 2020, Neuroendocrinology CrossRef
8. MiR-20b reverses 5-FU resistance in colon cancer cells by inhibiting JAK/STAT3 signaling pathway
   Ling-Zhi Yu et al, 2019, World Chinese Journal of Digestology CrossRef
9. A Renaissance in Therapeutic Options for Pancreatic Neuroendocrine Tumors
   Pamela L. Kunz, 2012, American Society of Clinical Oncology Educational Book CrossRef